ADVERTISEMENT

Stay up to date every week with the european biotechnology newsletter.

✕
This field is for validation purposes and should be left unchanged.
This field is hidden when viewing the form
EBcom NL
This field is hidden when viewing the form
Consent

Stay up to date every week with the european biotechnology newsletter.

Log in here to read the desired article.

This field is for validation purposes and should be left unchanged.
This field is hidden when viewing the form
EBcom NL
This field is hidden when viewing the form
Consent
go to the article

go back to the homepage

  • Subscription
  • Newsletter
  • Advertise
European Biotechnology Magazine
biocom_logo
  • Latest news
  • Background
  • Opinion
  • The Mag
    • Issues
    • Special
    • Corporate publications
    • Subscribe
  • Euro Biotech Guide
  • Market Place
    • Products
    • Sponsored Publications
    • Advertise
  • Associations
  • Service
    • Newsletter
    • Contact Us
    • Editorial Team
  • Events
  • Click to open the search input field Click to open the search input field Search
  • Menu Menu

ADVERTISEMENT

Corporate publications

bioRN02_Cover

life – the bioRN Life Science Cluster magazine No. 2

Alliances for success – the Heidelberg Ecosystem has it all – Heidelberg and the Rhine-Neckar region are among the most dynamic life science ecosystems in Europe. more ➔

life – the bioRN Life Science Cluster magazine No. 1

Alliances for success – the Heidelberg Ecosystem has it all – Heidelberg and the Rhine-Neckar region are among the most dynamic life science ecosystems in Europe. more ➔

ADVERTISEMENT

EB325_Automation&data sciences_Special_cover

AI in automation

AI has enormous potential in drug research and the life sciences. Investors have recognised this. Almost half of the US$165 billion raised for AI companies in the first half of 2025 went into this s … more ➔

12/12 TG angelegt, Ame + Grafik, please check13/12 TG korr Ame drin

Lab automation: New Modalities

More visitors, more exhibitors and more new product launches at SLAS Europe in Hamburg. more ➔

EB125_SLAS-Special_cover

Technology & System Integration

The world’s most important conference for laboratory automation and drug screening, SLAS 2025 International, saw a record of 409 exhibitors, 7,100 visitors and 99 market launches of products. The most … more ➔

LATEST NEWS

drug partnering

Enodia lands $500M Pfizer deal to target proteins a...

detection target

Elicera’s CAR-T clears detectable lymphoma in eig...

birch tree pollen

Desentum secures €28M for faster allergy immunoth...

ADVERTISEMENT

MAGAZINE

1 / 4
EBM 3.2026 Autumn_cover

The autumn issue of European Biotechnology magazine asks what happens when biotech leaves Earth. Our cover story explores how microgravity could help researchers study disease, improve drug formulations … more ➔

2 / 4

The summer issue of European Biotechnology Magazine showcases the latest developments in drug delivery and RNA technologies. This issue features a list of eight venture capital firms to watch in 2026. … more ➔

3 / 4

The Spring 2026 issue of European Biotechnology Magazine presents a list of start-ups to watch in 2026 and explores other fascinating topics such as: Can biotechnology finally fix infertility? Can … more ➔

4 / 4
EB425_Cover

Europe is losing much of its expertise in deep tech and life sciences to the US. To prevent another generation of innovation from being lost, Europe must close the funding gaps. more ➔

SPONSORED PUBLICATION

1 / 3
Celonic
Biosimilars

Perfusion for next generation biosimilars

Perfusion is here, and it is rewriting the rules of biologics and biosimilar manufacturing. What was once experimental has become industrial reality: scalable, robust, regulatorily accepted, and commercially … more ➔

2 / 3
eppendorf-new_CDMO115x65V2
CRO & CDMO

Every process is different. Not the platform.

For CDMOs, flexible upstream platforms can help streamline process ­development while maintaining reproducibility and continuity across scales. more ➔

3 / 3
Professor Jacob George, Chief Medical and Scientific Officer at the MHRA presenting his keynote speech at Phacilitate Advanced Therapies Europe, 2026
Cell & Gene Therapy

Europe’s CGT advantage at risk

Industry leaders at Advanced Therapies Europe 2026 warned that Europe must tackle barriers across commercialisation, regulation, reimbursement, manufacturing and patient access to retain its global … more ➔

newsletter_link
Knowbio GmbH
  • Link to LinkedIn
  • Link to Instagram
  • Contact
  • Imprint
  • Privacy policy
Scroll to top Scroll to top Scroll to top